Gregory W. Fulton ALS and Neuromuscular Disease Center
The Gregory W. Fulton ALS and Neuromuscular Disease Center was founded to improve both care and research for neuromuscular disorders, including amyotrophic lateral sclerosis (ALS), muscular dystrophy (MD), myasthenia gravis, myositis and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The ALS clinic is a model for offering complete multidisciplinary care within a single center while providing access to advanced clinical trials and promising basic research.
Amyotrophic lateral sclerosis (ALS)
The affliction known as ALS, aka Lou Gehrig’s Disease, is the quicksand of diseases. It often starts as weakness in a limb. Then over a few dreadful years it works its way toward the center of the body, extinguishing function as it goes, until it reaches the lungs. Death follows soon after.
The Gregory W. Fulton ALS and Neuromuscular Disease Center at Barrow brings together research and treatment for ALS and other neuromuscular diseases into one center in order to provide the best possible care for patients. A wide range of specialists collaborate at the center to maintain patients’ quality of life. In addition, patients have access to the latest scientific advances, thanks to the center’s research team, led by Robert Bowser, PhD, a respected ALS scientist formerly at the University of Pittsburgh.
A Winning Combination
Neurologist talks about the leadership ability and research expertise he brings to key new position at Barrow Neurological Institute.
Watch video and read more.
Researchers at Fulton ALS Center are part of international team that identifies Matrin 3 mutations as cause of some cases of familial ALS.
Gregory W. Fulton Center Opens
Generous donations bring first-of-its-kind center to the Southwest.